Zenbody review
Zenbody identifies different pharmacies for its injections and tablets and describes continuing clinical contact. Route and monitoring deserve as much attention as the first-month discount.
The verdict
Zenbody provides useful pharmacy transparency and distinguishes oral from injectable treatment. Before starting, confirm the medical professional responsible for follow-up and how the chosen formulation will be reviewed as your response changes.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Zenbody is an online platform for clinician-prescribed compounded semaglutide and tirzepatide. Its treatment pages offer an injected vial and a daily oral tablet, with evaluation, medicine and delivery described as included.
Who writes the prescription, and what do they see?
The legal terms identify independent professional organizations, including Remedora Inc., PC, whose licensed providers supply clinical services. Zenbody is separate from those practitioners. Confirm the individual clinician and the consent applicable to the patient’s state.
The product pages describe progress tracking, clinical-team messaging and check-ins. They do not establish one scheduled appointment interval or guaranteed clinical reply time for every patient. Ask how a symptom report reaches the prescriber before a new refill is prepared.
What happens when the dose goes up?
Zenbody says dose adjustments are included. Oral and injected compounded products use different routes and schedules, so the clinician should select and reassess the actual prescription rather than transpose a dose between formats.
What the price includes
Introductory and later prices differ by ingredient and format. Injection listings describe a four-week supply, while tablets are listed as thirty-day supplies. The clinical and fulfillment scope is included in the offer, but the actual continuing order should be confirmed before treatment begins.
What it claims, and what it cites
The injections are identified as filled by Rx Route in Tomball, Texas, and tablets by Epiq Scripts in Richardson, Texas. These compounded products are not FDA-approved. A named dispenser is useful information, but does not make a compounded tablet clinically interchangeable with an approved brand.
Where it holds up, and where it does not
- Strength: Injection and tablet pharmacies are named
- Strength: Clinical contact continues after dispensing
- Strength: Different supply formats are described
- Limitation: Follow-up frequency needs an individual agreement
- Limitation: First-month discounts do not describe later bills
- Limitation: Oral and injection evidence should not be conflated
What the evidence says about this kind of treatment
The assessment above is about Zenbody. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- Someone who wants a named pharmacy and can discuss the route, dose and monitoring plan before choosing compounded treatment.
- Wrong for
- Someone seeking an FDA-approved branded product or a guaranteed fixed interval of live appointments.
The evidence behind what Zenbody prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Zenbody compares
| Seller | Who it suits | Go |
|---|---|---|
| SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | See SkinnyRx → |
| ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | See ShedRx → |
| RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | See RxSpan MD → |
More GLP-1 telehealth sellers reviews: Tablet HealthTeladoc HealthTeleios HealthTeleWellnessMDThe ProtocoleTideMedix
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Which pharmacy fills Zenbody prescriptions?
- The product pages identify Rx Route for injections and Epiq Scripts for tablets. Confirm the pharmacy shown on the individual prescription.
- Does included messaging establish an immediate clinician response?
- No universal response guarantee was established in the reviewed public terms. Agree on the appropriate contact route before starting.
Sources for this review
Provider information checked . Terms can change.